Methotrexate vs Rituximab
Methotrexate vs Rituximab: Overview
This comparison examines the pharmacological differences between Methotrexate and Rituximab.
Mechanism of Action
Methotrexate: Dihydrofolate reductase inhibitor.
Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.
Pharmacokinetics
Half-life: Methotrexate β 3-10 hours; Rituximab β 22 days.
Chemical Properties
Molecular Formula: Methotrexate β C20H22N8O5.
Molecular Weight: Methotrexate β 454.4400 g/mol.
Type: Methotrexate β Small molecule; Rituximab β Antibody.